Question

GlaxoSmithKline, the global maker of medicines, vaccines, and consumer health-care products and headquartered in the United Kingdom, reported net cash inflow from operating activities of £6,250 million in 2011. The company included the following among its items in the investing and financing sections of its cash flow statement (in millions of British pounds):
Purchase of property, plant, and equipment ....... £ (923)
Purchase of intangible assets ............ (405)
Purchase of equity investments ........... (76)
Purchase of businesses, net of cash acquired ........ (264)
Dividends paid to shareholders ........... (3,406)
Compute GlaxoSmithKline’s free cash flow in at least two ways. Discuss the adequacy of the company’s free cash flow.



$1.99
Sales0
Views46
Comments0
  • CreatedFebruary 20, 2015
  • Files Included
Post your question
5000